Paul R. Buckman's most recent trade in Helius Medical Technologies Inc - Ordinary Shares - Class A was a trade of 2,600 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Helius Medical Technologie... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2025 | 2,600 | 2,600 | - | - | Stock Option (Right to Buy) | |
| NeuroOne Medical Technolog... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 50,000 | 50,000 | - | - | Option to Purchase Common Stock | |
| NeuroOne Medical Technolog... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 27,778 | 136,804 | - | 0 | Common Stock | |
| NeuroOne Medical Technolog... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 17,025 | 17,025 | - | - | Option to Purchase Common Stock | |
| Helius Medical Technologie... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 10,732 | 10,732 | - | - | Stock Option (Right to Buy) | |
| NeuroOne Medical Technolog... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.81 per share. | 01 Aug 2024 | 27,778 | 109,026 | - | 0.8 | 22,397 | Common Stock |
| NeuroOne Medical Technolog... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 20,834 | 20,834 | - | - | Warrants (Right to Buy) | |
| Helius Medical Technologie... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2024 | 31,000 | 31,000 | - | - | Stock Option (Right to Buy) | |
| Miromatrix Medical Inc | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 54,201 | 106,794 | - | 0 | Common Stock | |
| Helius Medical Technologie... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 284,865 | 284,865 | - | - | Stock Option (Right to Buy) | |
| Helius Medical Technologie... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 83,054 | 89,824 (0%) | 0% | 0 | Class A Common Stock | |
| NeuroOne Medical Technolog... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 20,576 | 81,248 | - | 0 | Common Stock | |
| NeuroOne Medical Technolog... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 18,927 | 18,927 | - | - | Option to Purchase Common Stock | |
| Miromatrix Medical Inc | Paul R. Buckman | Director | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 10 Mar 2023 | 31,250 | 52,593 | - | 1.6 | 50,000 | Common Stock |
| Miromatrix Medical Inc | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 12,788 | 21,343 | - | 0 | Common Stock | |
| NeuroOne Medical Technolog... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 29,240 | 60,672 | - | 0 | Common Stock | |
| NeuroOne Medical Technolog... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 29,230 | 29,230 | - | - | Option to Purchase Common Stock | |
| Helius Medical Technologie... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 21,605 | 21,605 | - | - | Stock Option (Right to Buy) | |
| Helius Medical Technologie... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 6,049 | 6,770 (0%) | 0% | 0 | Class A Common Stock | |
| Helius Medical Technologie... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 2,547 | 2,547 | - | - | Stock Option (Right to Buy) | |
| Helius Medical Technologie... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 721 | 721 (0%) | 0% | 0 | Class A Common Stock | |
| NeuroOne Medical Technolog... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 4,682 | 4,682 | - | - | Option to Purchase Common Stock | |
| NeuroOne Medical Technolog... | Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 4,592 | 31,424 | - | 0 | Common Stock |